Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 72 kDa (CEP72) is a member of the leucine-rich-repeat (LRR) superfamily and localizes to the centrosome, a non-membrane-bound organelle that serves as the major microtubule-organizing center in animal cells[3]. CEP72 functions as a centriolar satellite/pericentriolar material protein that is essential for recruitment and organization of key components for centrosome assembly, including γ-tubulin ring complexes, AKAP9, KIZ, and proteins involved in centriole duplication[1][3]. Its depletion impairs microtubule nucleation, disrupts spindle integrity, and affects chromosome alignment during mitosis; in mice, loss of Cep72 can cause abnormal sperm morphology but does not impair fertility[1][4]. There are currently no known drugs that directly target CEP72 and it is not a validated therapeutic target, but it plays a crucial role in fundamental processes such as cell division and may be implicated in certain disease contexts[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 72 kDa (CEP72).